beta-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis


beta-Elemene, a compound found in an herb used in traditional Chinese medicine, has shown promising anti-cancer effects against a broad spectrum of tumors. The mechanism by which beta-elemene kills cells remains unclear.

The aim of the present study is to investigate the anti-tumor effect of beta-elemene on human gastric cancer cells and the molecular mechanism involved.

Results: beta-Elemene inhibited the viability of human gastric cancer MGC803 and SGC7901 cells in a dose-dependent manner. The suppression of cell viability was due to the induction of apoptosis.

A robust autophagy was observed in the cells treated with beta-elemene; it was characterized by the increase of punctate LC3 dots, the cellular morphology, and the increased levels of LC3-II protein. Further study showed that beta-elemene treatment up-regulated Atg5-Atg12 conjugated protein but had little effect on other autophagy-related proteins.

PI3K/Akt/mTOR/p70S6K1 activity was inhibited by beta-elemene. Knockdown of Beclin 1 with small interfering RNA, or co-treatment with the autophagy inhibitor, 3-methyladenine or chlorochine enhanced significantly the antitumor effects of beta-elemene.

Conclusions: Our data provides the first evidence that beta-elemene induces protective autophagy and prevents human gastric cancer cells from undergoing apoptosis.

A combination of beta-elemene with autophagy inhibitor might thus be a useful therapeutic option for advanced gastric cancer.



Published on: 2011-05-20

Made available by EUPB via SpringerOpen / BioMedCentral. Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. To submit your press release click here.

Discussions




Custom Search



Username
Password










© 2017 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk